Our perspectives and foresight

SUMMARY This report is a portion of the dataset and information from our semi-annual State of Science survey. For additional information on particular segments or subsegments, please reach out to our team. In the semi-annual LINUS State of Science survey, we explore how scientists around the globe are adapting their priorities, productivity, and mindset based […]

Multiomics is widely regarded as key to understanding the complexity of biology, but how important is it to align on a singular definition of multiomics?

For our 2024 State of Science update, we heard from nearly 400 scientists on topics that span which technologies they'll be purchasing this year, their economic outlook, and their intent to collaborate with external partners.

In our semi-annual State of Science survey, we look into how scientists around the globe continue to adapt their priorities, productivity, and mindset, and how that may affect the life science industry. For the second half of 2023, we’re in a unique moment where there are immediate opportunities. LINUS CEO Hamid Ghanadan and DeciBio Partner Stephane Budel share market insights and answer your questions about the state of the industry.

In our semi-annual State of Science survey, we look into how scientists around the globe continue to adapt their priorities, productivity, and mindset, and how that may affect the life science industry. Add on the current economic climate, and we may be able to strategically plan priorities for the next year.